These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 16423573)
21. Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis. Shilkaitis A; Graves J; Mehta RR; Hu L; You M; Lubet R; Steele V; Kelloff G; Christov K Cell Growth Differ; 2000 Aug; 11(8):437-45. PubMed ID: 10965848 [TBL] [Abstract][Full Text] [Related]
22. Expression of the anti-apoptotic factors Bcl-2 and survivin in canine vascular tumours. Murakami M; Sakai H; Kodama A; Mori T; Maruo K; Yanai T; Masegi T J Comp Pathol; 2008 Jul; 139(1):1-7. PubMed ID: 18479697 [TBL] [Abstract][Full Text] [Related]
23. Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast. Vasaturo F; Sallusti E; Gradilone A; Malacrino C; Nardo T; Avagnano G; Aglianò AM; Granato T; De Vincenzi B; Coppotelli G; Marzullo A; Soda G; Simonelli L; Modesti M; Scarpa S Int J Oncol; 2005 Oct; 27(4):1005-11. PubMed ID: 16142317 [TBL] [Abstract][Full Text] [Related]
24. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer. Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411 [TBL] [Abstract][Full Text] [Related]
25. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome. Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours. Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888 [TBL] [Abstract][Full Text] [Related]
27. Tumour growth fraction and apoptosis in salivary gland acinic cell carcinomas. Prognostic implications of Ki-67 and bcl-2 expression and of in situ end labelling (TUNEL). Hellquist HB; Sundelin K; Di Bacco A; Tytor M; Manzotti M; Viale G J Pathol; 1997 Mar; 181(3):323-9. PubMed ID: 9155720 [TBL] [Abstract][Full Text] [Related]
28. Expression of the apoptotic markers in normal breast epithelium, benign mammary dysplasia and in breast cancer. Koda M; Kanczuga-Koda L; Reszec J; Sulkowska M; Famulski W; Baltaziak M; Kisielewski W; Sulkowski S Folia Morphol (Warsz); 2004 Aug; 63(3):337-41. PubMed ID: 15478112 [TBL] [Abstract][Full Text] [Related]
29. Expression of extracellular matrix metalloproteinase (MMP-9), E-cadherin and proliferation-associated antigen Ki-67 and their reciprocal correlation in canine mammary adenocarcinomas. Nowak M; Madej JA; Podhorska-Okolow M; Dziegiel P In Vivo; 2008; 22(4):463-9. PubMed ID: 18712173 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical expression of estrogen receptor beta in normal and tumoral canine mammary glands. Martín de las Mulas J; Ordás J; Millán MY; Chacón F; De Lara M; Espinosa de los Monteros A; Reymundo C; Jover A Vet Pathol; 2004 May; 41(3):269-72. PubMed ID: 15133176 [TBL] [Abstract][Full Text] [Related]
31. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887 [TBL] [Abstract][Full Text] [Related]
32. Expression of CD44 in canine mammary tumours. Paltian V; Alldinger S; Baumgärtner W; Wohlsein P J Comp Pathol; 2009 Nov; 141(4):237-47. PubMed ID: 19592009 [TBL] [Abstract][Full Text] [Related]
33. Vitamin D receptor expression in canine mammary gland and relationship with clinicopathological parameters and progesterone/oestrogen receptors. Sánchez-Céspedes R; Fernández-Martínez MD; Raya A; Pineda C; López I; Millán Y Vet Comp Oncol; 2018 Mar; 16(1):E185-E193. PubMed ID: 29178579 [TBL] [Abstract][Full Text] [Related]
34. Lymphocyte infiltration, expression of interleukin (IL) -1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours. Kim JH; Yu CH; Yhee JY; Im KS; Sur JH J Comp Pathol; 2010; 142(2-3):177-86. PubMed ID: 19959182 [TBL] [Abstract][Full Text] [Related]
35. MUC1 expression in canine malignant mammary tumours and relationship to clinicopathological features. de Oliveira JT; Pinho SS; de Matos AJ; Hespanhol V; Reis CA; Gärtner F Vet J; 2009 Dec; 182(3):491-3. PubMed ID: 18948041 [TBL] [Abstract][Full Text] [Related]
36. Metallothionein expression in canine and feline mammary and melanotic tumours. Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128 [TBL] [Abstract][Full Text] [Related]
37. A comparison of the effects of soya isoflavonoids and fish oil on cell proliferation, apoptosis and the expression of oestrogen receptors alpha and beta in the mammary gland and colon of the rat. Kramer F; Johnson IT; Doleman JF; Lund EK Br J Nutr; 2009 Jul; 102(1):29-36. PubMed ID: 19079816 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches. Rodo A; Malicka E Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536 [TBL] [Abstract][Full Text] [Related]
39. Quantification of VEGF-C expression in canine mammary tumours. Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481 [TBL] [Abstract][Full Text] [Related]
40. IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma. Garcia-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M Histopathology; 2005 Jul; 47(1):82-9. PubMed ID: 15982327 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]